Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
David Crews currently holds 694,957 shares of CYTOMEDIX INC (GTF), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, David Crews has been a net seller of GTF stock. They have purchased $46.1K and sold $156.1K worth of shares.
David Crews's most recent insider trade was on Sep 5, 2008, when they purchased 33,334 shares at $0.75 per share.
David Crews serves as Executive at CYTOMEDIX INC (GTF). They have executed 12 insider transactions totaling $202.2K over their tenure at the company.
David Crews holds the position of Executive at CYTOMEDIX INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
David Crews has shown a selling trading pattern, with $46.1K in total purchases and $156.1K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by David Crews was on Oct 1, 2007, when they sold $31.1K worth of GTF shares. This transaction involved 7,000 shares at $4.44 per share.
David Crews currently owns 694,957 shares of CYTOMEDIX INC (GTF), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of David Crews's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. David Crews has 12 Form 4 filings on record as an insider at CYTOMEDIX INC.
Set alerts for David Crews and 40,000+ other insiders.